- Axiom plans Hong Kong IPO, hoping to carve new path for US biotechsAxiom Biosciences is thinking outside of the box, betting on a public debut in Hong Kong to raise capital and grow into a global company.BioSpace · 6d ago↗ source
- A-Alpha Bio starts AI antibody data consortium with GSK, BoltzBiopharma's AI engines need more data. And David Younger thinks there's a great business to sell those data to them. Younger's startup, A-Alpha Bio, has spent months studying how protein-designin…Endpoints · 6d ago↗ source
- Recon: Novo sues Lilly over weight-loss drug ads; Gilead, Merck say HIV pill keeps HIV suppressed in two Phase 3 trials<p>Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.</p>raps · 6d ago